Stevens David Todd 4
4 · Figure Technology Solutions, Inc. · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
Figure (FIGR) CCO David Stevens Sells Shares After Option Exercise
What Happened David Todd Stevens, Chief Capital Officer of Figure Technology Solutions (FIGR), exercised 38,281 option shares on March 19, 2026 (exercise price $4.82; cost $184,514). On the same day he sold 49,708 common shares in three open‑market transactions for total proceeds of about $1.59 million (three weighted‑average sale prices reported). The filing also shows a related derivative conversion/disposition of 38,281 shares reported at $0, consistent with the option exercise/settlement reporting.
Key Details
- Transaction date: March 19, 2026 (Form 4 filed March 23, 2026 — within the two business‑day deadline).
- Option exercise (code M, Acquired): 38,281 shares @ $4.82 = $184,514. Footnote F5: these options vest 25% on Nov 11, 2025 and the remainder in 36 monthly installments.
- Open‑market sales (code S, Disposed):
- 19,998 shares, weighted avg price $31.45, proceeds $629,033 (prices ranged $30.89–$31.88) — F2.
- 24,630 shares, weighted avg price $32.28, proceeds $795,116 (prices ranged $31.89–$32.88) — F3.
- 5,080 shares, weighted avg price $33.00, proceeds $167,662 (prices ranged $32.89–$33.12) — F4.
- Sales executed pursuant to a Rule 10b5‑1 trading plan adopted Dec 10, 2025 (F1).
- The filing does not state the insider’s total shares owned after these transactions.
Context
- This filing shows an option exercise followed by open‑market sales reported under a prearranged 10b5‑1 plan. For retail investors, exercises are acquisitions of shares via derivative conversion; when those shares are sold the transactions are routine insider liquidity. The weighted‑average prices are reported; the filer has offered to provide a breakdown of individual trade prices on request.
Insider Transaction Report
Form 4
Stevens David Todd
Chief Capital Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2026-03-19$4.82/sh+38,281$184,514→ 485,797 total - Sale
Class A Common Stock
[F1][F2]2026-03-19$31.45/sh−19,998$629,033→ 465,799 total - Sale
Class A Common Stock
[F1][F3]2026-03-19$32.28/sh−24,630$795,116→ 441,169 total - Sale
Class A Common Stock
[F1][F4]2026-03-19$33.00/sh−5,080$167,662→ 436,089 total - Exercise/Conversion
Stock Option
[F5]2026-03-19−38,281→ 574,219 totalExercise: $4.82Exp: 2034-11-11→ Class A Common Stock (38,281 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.89 to $31.88. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.89 to $32.88. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.89 to $33.12. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The option vests with respect to one quarter of the underlying shares on November 11, 2025, and with respect to the remaining shares in 36 monthly installments thereafter.
Signature
/s/ Ronald Chillemi, Attorney-in-Fact|2026-03-23